The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kochergin N.G.

I.M. Sechenov Moscow Medical Academy

Petrunin D.D.

Pervyĭ MGMU im. I.M. Sechenova

The current view on the problem of the choice of medications for external therapy

Authors:

Kochergin N.G., Petrunin D.D.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2011;9(6): 84‑92

Read: 6099 times

Download PDF (RU)
Contact the author
Table of contents

THE CURRENT VIEW ON THE PROBLEM OF THE CHOICE OF MEDICATIONS FOR EXTERNAL THERAPY
THE CURRENT VIEW ON THE PROBLEM OF THE CHOICE OF MEDICATIONS FOR EXTERNAL THERAPY

To cite this article:

Kochergin NG, Petrunin DD. The current view on the problem of the choice of medications for external therapy. Russian Journal of Clinical Dermatology and Venereology. 2011;9(6):84‑92. (In Russ.)

Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Historical aspe­cts and prospects of psoriasis treatment. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):284-292
Abstract:

Keywords:

topical glucocorticosteroids
Lipocream
Crelo
external therapy
vehicles
topical glucocorticosteroids
Lipocream
Crelo
topical glucocorticosteroids
Lipocream
Crelo
external therapy
vehicles
topical glucocorticosteroids
Lipocream
Crelo

Authors:

Kochergin N.G.

I.M. Sechenov Moscow Medical Academy

Petrunin D.D.

Pervyĭ MGMU im. I.M. Sechenova

Close metadata

References:

  1. et al. Sovremennaya naruzhnaya terapiya dermatozov (s elementami fizioterapii). Pod red. N.G. Korotkogo. Tver': Gubernskaya meditsina 2001; 528.
  2. et al. Osnovy naruzhnoi terapii boleznei kozhi. Vaskulity kozhi. Pod red. E.V. Sokolovskogo. St-Peterburg: Sotis 1999; 198.
  3. Del Rosso J., Friedlander S.F. Corticosteroids: options in the era of steroid-sparing therapy. J Am Acad Dermatol 2005; 53: S50-S58.
  4. Schafer-Korting M., Kleuser B., Ahmed M. et al. Glucocorticoids for human skin: new aspects of the mechanism of action. Skin Pharmacol Physiol 2005; 18: 103-114.
  5. Brazzini B., Pimpinelli N. New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutic use. Am J Clin Dermatol 2002; 3: 1: 47-58.
  6. Tadicherla S., Ross K., Shenefelt P. et al. Topical corticosteroids in dermatology. J Drugs Dermatol 2009; 8: 12: 1093-1105.
  7. Daniels R., Knie U. Galenics of dermal products-vehicles, properties and drug release. JDDG 2007; 5: 367-383.
  8. Ricciatti-Sibbald D., Sibbald R.G. Dermatologic vehicles. Clin Dermatol 1989; 7: 3: 11-24.
  9. Griffiths W.A.D., Wilkinson J.D. Topical therapy. In: Rook, Wilkinson, Ebling Textbook of Dermatology. Eds. R.H. Champion, J.L. Burton, F.J.G. Ebling. London: Blackwell Scientific 1992; 3037-3084.
  10. Thoma K. Dermatika. MÜnchen, Werbe- und Vertriebsgesellschaft Deutscher Apotheker 1983; 462.
  11. MÜller K.H. Systematik der Externa. Fette Seifen Anstrichmittel 1979; 81: 133-136.
  12. Katz M. Design of topical drug products.: Pharmaceutics. In: Drug Design. Ed. E.J. Ariëns. New York: Academic Press 1973; 93-148.
  13. Surber C., Smith E.W. The mystical effects of dermatological vehicles. Dermatology 2005; 210: 157-168.
  14. Juch R.D., Rufli T., Surber C. Pastes: what do they contain? How do they work? Dermatology 1994; 189: 373-377.
  15. Lorincz A.L. The pharmacology of topically applied medications. In: The Evaluation of Therapeutic Agents and Cosmetics. Ed.: T.H. Sternberg, V.D. Newcomer. New York: McGraw-Hill 1964; 86-94.
  16. Heisel E.W. Principles of local dermatologic therapy. In: Dermatologic Allergy: Immunology, Diagnosis and Management. Ed. L.H. Criep. Philadelphia: Saunders 1967; 540-558.
  17. Obata M., Tagami H. A rapid in vitro test to assess skin moisturizers.
  18. Fowler J.F. Disulfiram is effective for nickel-allergic hand eczema. Am J Contact Dermatitis 1992; 3: 175-178.
  19. Wolf R. Has mildness replaced cleanliness next to godliness? Dermatology 1994; 189: 217-221.
  20. Hills R.J., Unsworth A., Ive F.A. A comparative study of the frictional properties of emollient bath additives using porcine skin. Br J Dermatol 1994; 130: 37-41.
  21. Gabard B. Testing the efficacy of moisturizers. In: Bioengineering of the Skin: Water and Stratum corneum. Eds. P. Elsner, E. Berardesca, H.I. Maibach. Boca Raton: CRC Press 1994; 147-170.
  22. Kondo S., Yamanaka C., Sugimoto I. Enhancement of transdermal delivery by superfluous thermodynamic potential. III. Percutaneous absorption of nifedipine in rats. J Pharmacobiodyn 1987; 10: 743-749.
  23. Megrab N.A., Williams A.C., Barry B.W. Oestradiol permeation through human skin and Silastic membrane: effects of propylene glycol and supersaturation. J Contr Rel 1995; 36: 277-294.
  24. Sato K., Sugibayashi K., Morimoto Y. Effect and mode of action of aliphatic esters on the in-vitro skin permeation of micorandil. Int J Pharm 1988; 43: 31-40.
  25. Yamane M.A., Williams A.C., Barry B.W. Effects of terpenes and oleic acid as skin penetration enhancers towards 5-fluorouracil as assessed with time; permeation, partitioning and differential scanning calorimetry. Int J Pharm 1995; 116: 237-251.
  26. Danon A., Horowitz J., Ben-Zvi Z. et al. An outbreak of digoxin intoxication. Clin Pharmacol Ther 1977; 21: 643-646.
  27. Melikian A.P., Straughn A.B., Slywka G.W.A. et al. Bioavailability of 11 phenytoin products. J Pharmacokinet Biopharm 1977; 5: 133-146.
  28. Glazko A.J., Kinkel A.W., Alegnani W.C., Holmes E.L. An evaluation of the absorption characteristics of different chloramphenicol preparations in normal human subjects. Clin Pharmacol Ther 1968; 9: 472-483.
  29. Hengge U.R., Ruzicka T., Schwartz R.A., Cork M.J. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol 2006; 54: 1-15.
  30. Cornell R.C., Stoughton R.B. Correlation of the vasoconstriction assay and clinical activity in psoriasis. Arch Dermatol 1985; 121: 63-67.
  31. Miller J.A., Munro D.D. Topical corticosteroids: clinical pharmacology and therapeutic use. Drugs 1980; 19: 119-134.
  32. Pierard G.E. Hydrocortisone 17-butyrate (Locoid), a thirty-year ongoing innovative drug. Rev Med Liege 2006; 61: 2: 128-130.
  33. Wieriks J., Hespe W., Jaitly K.D., van Kan B.L. Topical and systemic effects of hydrocortisone 17-butyrate. Dermatologica 1976; 152: Suppl 1: 181-195.
  34. Belikov O.E., Puchkova T.V. Konservanty v kosmetike i sredstvakh gigieny. M: Shkola kosmeticheskikh khimikov 2003; 250.
  35. Korsunskaya I.M., Lukashova N.A., Nevozinskaya Z.A., Agafonova E.E. Rezul'taty issledovaniya effektivnosti negalogenizirovannykh kortikosteroidov v terapii khronicheskoi ekzemy. Klin dermatol i venerol 2008; 4: 101-105.
  36. Mulder D., Bekker J., Kuligowski M.E. Expert report on the clinical documentation of Locoid Lipocream. Yamanouchi Europe B.V. 2003.
  37. Jemec G.B.E., Wulf H.C. Correlation between the greasiness and the plasticizing effect of moisturizers. Acta Dermatol Venereol 1999; 79: 115-117.
  38. Halkier-Sorensen L., Thestrup-Pedersen K. The efficacy of a moisturizer (Locobase) among cleaners and kitchen assistants during everyday exposure to water and detergents. Contact Dermatitis 1993; 29: 266-271.
  39. Gip L., Verjans H.L. Hydrocortisone 17-butyrate 0,1% Lipocream vs betamethasone 17-valerate 0,1% cream in the treatment of patients with dry severe chronic eczema. Curr Ther Res 1987; 41: 258-264.
  40. Guillet G., Nougue J. Etude comparative en double aveugle de deux dermocorticoides dans l'eczema aigu ou chronique 17-butyrate d'hydrocortisone créme epaisse versus dipropionate d'betamethasone pomade. Ther Pharmacol Clin 1989; 7: 79: 10-17.
  41. Letawe C., Pierard-Franchimont C., Pierard G.E. Squamometry in rating the efficacy of topical corticosteroids in atopic dermatitis. Eur J Clin Pharmacol 1996; 51: 3-4: 253-257.
  42. Fowler J.F., Fransway A.F., Jackson J.M., Rohowsky N. Hydrocortisone butyrate 0,1% cream in the treatment of chronic dermatitis. Cutis 2005; 75: 125-131.
  43. Berbis P., Hesse S., Privat Y. Essential fatty acids and the skin. Allerg Immunol 1990; 22: 6: 225-231.
  44. Niedner R., Degen A. Lokaltherapie der Psoriasis capilliti mit einer Hydrocortison-17- Butyrat-Emulsion im Vergleich zu einer Betamethason-17-Valerat-Lotion. Dtsch Dermatol 1993; 2: 198-200.
  45. Pierard G.E., Lachapelle J.M., Frentz G. et al. Hydrocortisone 17-butyrate topical emulsion (Locoid Crelo) in psoriasis. J Eur Acad Dermatol Venereol 1996; 6: 11-14.
  46. de Cuyper C., Degreef H.J., de la Brassinne M. et al. A randomized, single-blind study to compare hydrocortisone 17-butyrate 0,1% emulsion (HCB) versus betamethasone 17,21-dipropionate 0,05% lotion in the treatment of patients suffering from psoriasis of the scalp. J Eur Acad Dermatol Venereol 1995; 5 : Suppl 1: S104-S105.
  47. Jacoby H. A randomized, single-blind study to compare clinically and by squamometry the effect of Locoid (hydrocortisone 17-butyrate 0,1%) Crelo versus Diprosone (betamethasone 17,21-dipropionate 0,05%) lotion on the structure of stratum corneum in patients suffering from seborrhoeic dermatitis. Yamanouchi Doc 1998; 701: 1-56.
  48. Korstanje C., Ligtvoet F.P.T., Van Hemert K.H.F. Differential effects of dermatological cream bases with respect to skin surface moisturizing capacity: a study design in volunteers. J Dermatol Treat 1992; 2: 137-139.
  49. Korstanje C. Comparison of Locoid preparations with competitors in the skin hydration assay in healthy human volunteers. Yamanouchi Data on file 1991; IMP-91-03.
  50. Polano M.K. Topical Skin Therapeutics. Edinburgh: Churchill Livingstone 1984; 197.
  51. Hundeiker M. Grundlagen der Therapie mit äusserlichen Arzneimittelzubereitungen. Zentralbl Hautkr 1982; 148: 683-697.
  52. Schaefer H., Zesch A., Stüttgen G. Skin Permeability. Berlin 1982; 599.
  53. Barry B.W. Dermatological formulations: percutaneous absorption. New York: Dekker 1983; 480.
  54. Ive A., Comaish S. Topical therapy. Recent Adv Dermatol 1980; 5: 285-315.
  55. Niedner R. Grundprinzipien der dermatologischen Therapie. In: Dermatika. Hrsg. Niedner, Ziegenmeyer. Stuttgart: Wiss Verlagsges 1992; 37-52.
  56. Schlossmann M.L. Formulating ethnic makeup products. J Cosmet Toilet 1995; 110: 59-63.
  57. Sugino K., Imokawa G., Maibach H.I. Ethic difference of stratum corneum lipid in relation to stratum corneum function. J Invest Dermatol 1993; 100: 597-601.
  58. Breuer K., Braeutigam M., Kapp A., Werfel T. Influence of pimecrolimus cream 1% on different morphological signs of eczema in infants with atopic dermatitis. Dermatology 2004; 209: 314-320.
  59. Gabard B. Testing the efficacy of moisturizers. In: Bioengineering of the Skin: Water and Stratum corneum. Eds. P. Elsner, E. Berardesca, H.I. Maibach. Boca Raton: CRC Press 1994; 147-170.
  60. Lodén M. The increase in skin hydration after application of emollients with different amounts of lipids. Acta Dermatol Venereol (Stockh) 1992; 72: 327-330.
  61. Choudhury T.H., Marty J.P., Orecchini A.M. et al. Factors on the occlusivity of aqueous emulsions. Influence of Humectants. J Soc Cosmet Chem 1985; 36: 255-269.
  62. Feldmann R.J., Maibach H.I. Regional variation in percutaneous penetration of 14C cortisol in man. J Invest Dermatol 1967; 48: 181-183.
  63. Maibach H.I., Feldmann R.J., Milby T.H., Serat W.F. Regional variations in percutaneous penetration in man: pesticides. Arch Environ Health 1971; 23: 208-211.
  64. Wester R.C., Maibach H.I. Dermatopharmacokinetics in clinical dermatology. Semin Dermatol 1983; 2: 81-84.
  65. Meyer E., Smith E.W., Haigh J.M. Sensitivity of different areas of the flexor aspect of the human forearm to corticosteroid-induced skin blanching. Br J Dermatol 1992; 127: 379-381.
  66. Shuster S. Understanding skin disease. Triangle 1987; 26: 125-138.
  67. Grimm W. International harmonization of stability tests for pharmaceuticals: The ICH tripartite guideline for stability testing of new drug substances and products. Eur J Pharm Biopharm 1995; 41: 194-196.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.